Chronic obstructive pulmonary disease and comorbidities (CROSBI ID 633513)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Sokolović, Irena ; Knežević, Jelena ; Popović-Grle, Sanja ; Vukić Dugac, Andrea ; Bubanović, Gordana ; Janković Makek, Mateja ; Hećimović, Ana ; Redžepi, Gzim ; Samaržija, Miroslav ; Jakopovic, Marko
engleski
Chronic obstructive pulmonary disease and comorbidities
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide. Although it is well known that comorbidities are highly prevalent in patients with COPD, they are not considered for treatment effect analysis. To observe frequency of comorbidities in patients with COPD and compare its distribution in 4 GOLD groups. Observational cross sectional study was designed to identify comorbidities related with categorized disease groups. Patients with COPD treated at University Hospital Centre were included. Severity of COPD was estimated and number of comorbidities was counted. Comorbidity was defined as the presence of disorder in addition to COPD irrespective of their relation to COPD. We enrolled 460 COPD patients (68, 5% males ; average age at diagnosis 61, 3 years. Majority of patients were in GOLD group A (41%) and B (29%), followed by group D (25%) and C (5%). Comorbidities were present in 90% of patients, with 31% of patients with 1 comorbidity, 31% with 2 comorbidities and 28% with 3 or more (mean of 1.9). There was no significant difference in number of comorbidities among GOLD groups (P=0.81). Most common comorbidities were arterial hypertension (47%), lung neoplasm (40%) and cardiovascular diseases (23%). We showed that COPD is rarely diagnosed as an isolated condition, since different comorbidities were present in 90% of patients. Hypertension, lung neoplasms and cardiovascular diseases were revealed as the most common ones. High proportion of lung cancer can be attributed to searching for COPD in lung cancer patients. A multidimensional COPD diagnosis approach should be taken into account when classifying COPD patients into GOLD groups.
Chronic obstructive lung diseases
DOI: 10.1183/13993003.congress-2015.PA1123
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
PA1123 P-PA1123 P.
2015.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
The European respiratory journal
0903-1936
Podaci o skupu
Annual Congress of the European Respiratory Society (25 ; 2015)
poster
26.09.2015-30.09.2015
Amsterdam, Nizozemska
Povezanost rada
Kliničke medicinske znanosti